Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.
Atkins
Michael B
MB
Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. Matkins@bidmc.harvard.edu
Regan
Meredith
M
McDermott
David
D
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging
D016207:Cytokines; D016898:Interferon-alpha; D007376:Interleukin-2